Showing results (401-410 of 777) with videos related to

Sort By:
Pageof 78
The American Journal of Pathology|December 7, 2006
Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodelingMarina Morigi, Simona Buelli, Cristina Zanchi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic backgroundElena Bresin, Erica Daina, Marina Noris, et al.
Nephron|April 28, 2021
Characterization of a Rat Model of Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Crescentic GlomerulonephritisDomenico Cerullo, Daniela Rottoli, Daniela Corna, et al.
The CRISPR Journal|April 19, 2019
CRISPR-Cas9-Mediated Correction of the G189R-PAX2 Mutation in Induced Pluripotent Stem Cells from a Patient with Focal Segmental GlomerulosclerosisPiera Trionfini, Osele Ciampi, Marta Todeschini, et al.
Cells|September 13, 2025
Correction: Pezzotta et al. Low Nephron Number Induced by Maternal Protein Restriction Is Prevented by Nicotinamide Riboside Supplementation Depending on Sirtuin 3 Activation. Cells 2022, 11, 3316Anna Pezzotta, Luca Perico, Marina Morigi, et al.
Cells|October 27, 2022
Low Nephron Number Induced by Maternal Protein Restriction Is Prevented by Nicotinamide Riboside Supplementation Depending on Sirtuin 3 ActivationAnna Pezzotta, Luca Perico, Marina Morigi, et al.
Plos One|January 26, 2016
Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-AnalysisPietro Amedeo Modesti, Gianpaolo Reboldi, Francesco P Cappuccio, et al.
Kidney International|April 21, 2005
Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusionDaniela Cugini, Nadia Azzollini, Elena Gagliardini, et al.
Kidney International|June 16, 2005
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney diseasePiero Ruggenenti, Andrea Remuzzi, Patrizia Ondei, et al.
Journal of Hypertension|October 8, 2009
Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuriaMatthew R Weir, Norman K Hollenberg, Dion H Zappe, et al.
Pageof 78